Cargando…
GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes
INTRODUCTION: Experimentally, gamma-aminobutyric acid (GABA) has been found to exert immune-modulatory effects and induce beta-cell regeneration, which make it a highly interesting substance candidate for the treatment of type 1 diabetes (T1D). In many countries, including those in the European Unio...
Autores principales: | Espes, Daniel, Liljebäck, Hanna, Hill, Henrik, Elksnis, Andris, Caballero-Corbalan, José, Birnir, Bryndis, Carlsson, Per-Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506884/ https://www.ncbi.nlm.nih.gov/pubmed/34635547 http://dx.doi.org/10.1136/bmjdrc-2021-002442 |
Ejemplares similares
-
Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes
por: Hill, Henrik, et al.
Publicado: (2021) -
Unsurpassed Intrahepatic Islet Engraftment – the Quest for New Sites for Beta Cell Replacement
por: Liljebäck, Hanna, et al.
Publicado: (2019) -
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes
por: Espes, Daniel, et al.
Publicado: (2022) -
Functional Characterization of Native, High-Affinity GABA(A) Receptors in Human Pancreatic β Cells
por: Korol, Sergiy V., et al.
Publicado: (2018) -
GABA Regulates Release of Inflammatory Cytokines From Peripheral Blood Mononuclear Cells and CD4(+) T Cells and Is Immunosuppressive in Type 1 Diabetes
por: Bhandage, Amol K., et al.
Publicado: (2018)